BR112014011868A2 - composições corantes poliméricas e métodos de uso - Google Patents

composições corantes poliméricas e métodos de uso

Info

Publication number
BR112014011868A2
BR112014011868A2 BR112014011868A BR112014011868A BR112014011868A2 BR 112014011868 A2 BR112014011868 A2 BR 112014011868A2 BR 112014011868 A BR112014011868 A BR 112014011868A BR 112014011868 A BR112014011868 A BR 112014011868A BR 112014011868 A2 BR112014011868 A2 BR 112014011868A2
Authority
BR
Brazil
Prior art keywords
methods
polymeric
polymeric dye
dye compositions
component
Prior art date
Application number
BR112014011868A
Other languages
English (en)
Portuguese (pt)
Inventor
B Olson David
Zhu Dong-Wei
A Hanggi Douglas
C Haddad Louis
T Scholz Matthew
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BR112014011868A2 publication Critical patent/BR112014011868A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44Guanidine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
BR112014011868A 2011-11-16 2012-11-16 composições corantes poliméricas e métodos de uso BR112014011868A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161560407P 2011-11-16 2011-11-16
PCT/US2012/065404 WO2013074860A1 (en) 2011-11-16 2012-11-16 Polymeric colorant compositions and methods of use

Publications (1)

Publication Number Publication Date
BR112014011868A2 true BR112014011868A2 (pt) 2017-05-16

Family

ID=47222342

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014011868A BR112014011868A2 (pt) 2011-11-16 2012-11-16 composições corantes poliméricas e métodos de uso

Country Status (7)

Country Link
US (1) US9717798B2 (enExample)
EP (1) EP2779998A1 (enExample)
JP (1) JP2014533693A (enExample)
CN (1) CN104039310A (enExample)
BR (1) BR112014011868A2 (enExample)
IN (1) IN2014CN03706A (enExample)
WO (1) WO2013074860A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140276354A1 (en) * 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
WO2015158467A1 (en) * 2014-04-14 2015-10-22 Unilever N.V. Skin care composition
EP3131526B1 (en) * 2014-04-14 2017-11-01 Unilever N.V. Skin care composition
DE102014107412A1 (de) * 2014-05-26 2015-12-17 Schülke & Mayr GmbH Gefärbte desinfizierende Zubereitung auf Basis von Bispyridiniumalkan
US10091991B2 (en) 2014-12-01 2018-10-09 Greenway Pest Products, Llc Antimicrobial films
JP6810360B2 (ja) * 2016-03-09 2021-01-06 Jsr株式会社 インク、捺染方法及びテキスタイル用インク剤
WO2018085389A1 (en) * 2016-11-01 2018-05-11 Milliken & Company Leuco polymers as bluing agents in laundry care compositions
WO2018085386A1 (en) * 2016-11-01 2018-05-11 Milliken & Company Leuco polymers as bluing agents in laundry care compositions
US10501633B2 (en) * 2016-11-01 2019-12-10 Milliken & Company Leuco polymers as bluing agents in laundry care compositions
EP3703824A1 (en) 2017-10-31 2020-09-09 Rohm and Haas Company Multistage colored polymer particle and skin care formulations comprising same
US12390487B2 (en) 2019-04-05 2025-08-19 Solventum Intellectual Properties Company Antiseptic skin prep composition
DE102019219708A1 (de) * 2019-12-16 2021-06-17 Henkel Ag & Co. Kgaa Verfahren zum Färben von keratinischem Material, umfassend die Anwendung von einer siliciumorganischen Verbindung, eines Hydroxycarbonsäureesters, eines Diols und einer farbgebenden Verbindung

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300513A (enExample) * 1963-05-06
US4051138A (en) * 1975-12-08 1977-09-27 Dynapol Water-soluble amine-linked polymeric colorants
US4542012A (en) 1982-07-02 1985-09-17 Minnesota Mining And Manufacturing Company Film-forming composition containing an antimicrobial agent and methods
US4584192A (en) 1984-06-04 1986-04-22 Minnesota Mining & Manufacturing Company Film-forming composition containing an antimicrobial agent and methods of use
SE454842B (sv) * 1984-11-01 1988-06-06 Pharmacia Ab Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne
US5367370A (en) 1992-06-11 1994-11-22 Mita Industrial Co., Ltd. Mounting apparatus for a document-placing table on an image forming machine document feeder
US5288159A (en) 1992-12-04 1994-02-22 Minnesota Mining And Manufacturing Company Liquid applicator with frangible ampoule and support
PL174222B1 (pl) * 1993-01-27 1998-06-30 Inst Farmaceutyczny Środek farmaceutyczny działający na ośrodkowy układ nerwowy
US5547662A (en) 1993-08-27 1996-08-20 Becton, Dickinson And Company Preparation of a skin surface for a surgical procedure
CN1178712C (zh) 1998-01-30 2004-12-08 美国3M公司 手术准备液涂药器和方法
US6420455B1 (en) 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
EP1081025B1 (en) 1999-09-02 2004-12-29 Nissan Motor Company, Limited Body structure in floor section of vehicle
GB9920774D0 (en) 1999-09-03 1999-11-03 Avecia Ltd Polymer
US6422778B2 (en) 2000-04-03 2002-07-23 3M Innovative Properties Company Surgical prep solution applicator system and methods
US6432396B1 (en) 2000-07-06 2002-08-13 3M Innovative Properties Company Limiting the presence of microorganisms using polymer-bound metal-containing compositions
US7459167B1 (en) 2000-07-27 2008-12-02 3M Innovative Properties Company Biocidal polyurethane compositions and methods of use
US6605666B1 (en) 2000-07-27 2003-08-12 3M Innovative Properties Company Polyurethane film-forming dispersions in alcohol-water system
JP2002361908A (ja) 2000-11-15 2002-12-18 Seiko Epson Corp 液体噴射装置、及び、噴射ヘッドのクリーニング方法
BR0210979A (pt) * 2001-06-08 2004-06-08 David S Soane Composições de protetor solar colorido
US7030203B2 (en) 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
FR2830776A1 (fr) * 2001-10-16 2003-04-18 Oreal Nanocapsules a base de polyesters sulfoniques hydrodispersibles colores
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US6838078B2 (en) 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US6930184B2 (en) 2002-07-26 2005-08-16 3M Innovative Properties Company Functional fluorescent dyes
US7261701B2 (en) 2002-10-03 2007-08-28 3M Innovative Properties Co. Skin antiseptic composition dispenser and methods of use
US6729786B1 (en) 2003-03-14 2004-05-04 Mediflex Hospital Products, Inc. Liquid applicator for coloring a liquid
US7273896B2 (en) * 2003-04-10 2007-09-25 Angiotech Pharmaceuticals (Us), Inc. Compositions and methods of using a transient colorant
EP1489144A1 (en) 2003-06-18 2004-12-22 DSM IP Assets B.V. Water-soluble polymeric dye
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20060051384A1 (en) 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
CA2581883A1 (en) * 2004-09-27 2006-04-06 Technion Research & Development Foundation Ltd. Novel antimicrobial agents
US20080175811A1 (en) 2005-05-16 2008-07-24 Novapharm Research (Australia) Pty Ltd. Method and Composition For Use In Preparation of a Patient For Surgery
CN101489379B (zh) 2006-10-27 2014-06-04 3M创新有限公司 抗微生物组合物
BRPI0819567A2 (pt) 2007-12-31 2015-05-05 3M Innovative Properties Co "composições antimicrobianas, método para aprimorar a adesão molhada do artigo adesivo médico e método para evitar ou tratar uma condição da pele de um mamífero
AU2009204189B2 (en) * 2008-01-08 2014-01-16 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
MX2011006181A (es) 2008-12-15 2011-06-20 Basf Se Polimeros para el cabello.

Also Published As

Publication number Publication date
WO2013074860A1 (en) 2013-05-23
EP2779998A1 (en) 2014-09-24
US20140323578A1 (en) 2014-10-30
US9717798B2 (en) 2017-08-01
JP2014533693A (ja) 2014-12-15
CN104039310A (zh) 2014-09-10
IN2014CN03706A (enExample) 2015-10-09

Similar Documents

Publication Publication Date Title
BR112014011868A2 (pt) composições corantes poliméricas e métodos de uso
NI201100082A (es) Compuestos de isoindolina para uso en el tratamiento de cáncer.
BR112012031727A2 (pt) conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença.
BR112015005940A2 (pt) processo para a preparação de nanopartículas terapêuticas
BR112016009669A8 (pt) produtos farmacêuticos, método para tratar câncer e uso de um composto
CY1118216T1 (el) Μεθοδοι αγωγης καρκινου
BRPI0921687A2 (pt) Composto , conjugado , uso de um composto , composição farmacêutica, processo para preparar uma composição famacêutica , método para tratar um mamífero em necessidade do mesmo ,e, método para tratar ou prevenir um tumor em um mamífero.
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
BR112012008889A2 (pt) compostos de espiropiperidina e uso farmacêutico dos mesmos para tratar diabetes
BRPI0918313A2 (pt) Agente antiperspirante multicomponente, processo para tratar a perspiração humana, uso de um agente multicomponente e dispositivo com múltiplos compartimentos ou kit
BR112014030386A8 (pt) Compostos e composições para modular a atividade de egfr
BRPI0613401B8 (pt) composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior
CL2009001240A1 (es) Compuestos derivados del acido l-glutamico y l-glutamina marcados con [f-18]; procedimiento de preparacion; composicion farmaceutica que comprende a los compuestos y su uso como agentes en el diagnostico de tumores.
BR112012022337A2 (pt) composição e respectivos método de preparação e uso de quantidade eficaz
AR078736A1 (es) Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion
MX2010009743A (es) Uso de derivados de pirimidina para el tratamiento de las enfermedades dependientes de los receptores del factor de crecimiento epidermico (egfr) o de enfermedades que hayan adquirido resistencia a los agentes que se dirigen a los miembros de la fami
BRPI0920655A2 (pt) conjugados e hpma-docetaxel ou gencitabina e usos dos mesmos
BRPI0922524B8 (pt) estrutura semelhante a coágulo de fibrina, e, usos de uma estrutura semelhante a coágulo de fibrina, e de uma preparação de uma estrutura semelhante a coágulo de fibrina
Pappinen et al. Organotypic cell cultures and two-photon imaging: tools for in vitro and in vivo assessment of percutaneous drug delivery and skin toxicity
BRPI0905687A8 (pt) composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto
BR112014025702A2 (pt) compostos de tiofeno fotodinâmicos a base de metal e seus usos
ECSP099426A (es) Compuestos de 4-hidroxi-2-oxo-2,3-dihidro-1,3-benzotiazol-7il para la modulación de la actividad del adrenoreceptor beta2
BR112013009624A2 (pt) uso de derivados de 2-carboxamida cicloamino ureia no tratamento de doenças dependemtes de egfr pu doenças que tenham adquirido resistência a agentes que tenham como alvo membros da família egfr
BRPI0821555A2 (pt) Componente para uma vaciana de hiv ou massa, componente ou massa líquida liofilizados, composição farmacêutica ou vacina, usos do componente ou massa final ou da composição farmacêutica e de um antioxidante com pelo menos um grupo funcional tiol e métodos de tratamento e de reconstituição de um componente liofilizado, e kit
BR112015029550A2 (pt) Anticorpo anti-vegf e composição farmacêutica para prevenção, diagnóstico ou tratamento de câncer ou doença relacionada à angiogênese contendo o mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11T Dismissal of application maintained [chapter 11.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]